Page last updated: 2024-08-24

imiquimod and Fifth Phacomatosis

imiquimod has been researched along with Fifth Phacomatosis in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (58.33)29.6817
2010's4 (33.33)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Bartenstein, DW; Fisher, J; Hawryluk, EB; Kroshinsky, D; Lilly, E; Moustafa, D; Su, KA1
Cabanillas, M; Monteagudo, B; Peña-López, S; Suárez-Magdalena, O1
Argenziano, G; Drummond, A; Lallas, A; Longo, C; Moscarella, E; Piana, S; Pichler, J; Zalaudek, I1
Krekels, GA; Ostertag, JU; van der Geer, S1
Bonnekoh, B; Fehsecke, D; Franke, I; Froster, UG; Gollnick, HP; Helmdach, M; Kraus, C; Quist, SR; Reis, A1
Marghoob, AA; Tang, JY1
Caltabiano, R; De Pasquale, R; Impallomeni, R; Lacarrubba, F; Micali, G1
De Pasquale, R; Lacarrubba, F; Micali, G; Nasca, MR1
Heenen, M; Monsieur, E; Petein, M; Vereecken, P1
Ferreres, JR; Jucglà, A; Macaya, A; Muniesa, C; Peyrí, J; Prats, C1
Mitropoulos, P; Norman, R1
Amonette, R; Kagy, MK1

Reviews

3 review(s) available for imiquimod and Fifth Phacomatosis

ArticleYear
Treatment of basal cell carcinomas in patients with nevoid basal cell carcinoma syndrome.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:3

    Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Humans; Imiquimod; Laser Therapy; Photochemotherapy; Skin Neoplasms

2009
Emerging treatments and signaling pathway inhibitors.
    Seminars in cutaneous medicine and surgery, 2011, Volume: 30, Issue:4 Suppl

    Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Basal Cell Nevus Syndrome; Benzamides; Carcinoma, Basal Cell; Deoxyribonuclease (Pyrimidine Dimer); Fluorouracil; Hedgehog Proteins; Humans; Imiquimod; Photochemotherapy; Pyridines; Quinazolines; Retinoids; Secondary Prevention; Signal Transduction; Skin Neoplasms; Viral Proteins

2011
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments.
    Cutis, 2008, Volume: 81, Issue:1

    Topics: Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurgery; Electrochemotherapy; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Interferons; Photochemotherapy; Randomized Controlled Trials as Topic; Retinoids; Skin Neoplasms

2008

Other Studies

9 other study(ies) available for imiquimod and Fifth Phacomatosis

ArticleYear
A pediatric approach to management of skin growths in basal cell nevus syndrome.
    Pediatric dermatology, 2020, Volume: 37, Issue:3

    Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Child; Child, Preschool; Fluorouracil; Humans; Imiquimod; Skin Neoplasms

2020
Erythema Multiforme Caused by Treatment With Topical Imiquimod 5% in a Patient With Gorlin Syndrome.
    Actas dermo-sifiliograficas, 2018, Volume: 109, Issue:3

    Topics: Administration, Topical; Antineoplastic Agents; Basal Cell Nevus Syndrome; Drug Eruptions; Erythema Multiforme; Female; Humans; Imiquimod; Middle Aged

2018
Lichen planopilaris after imiquimod 5% cream for multiple BCC in basal cell naevus syndrome.
    The Australasian journal of dermatology, 2015, Volume: 56, Issue:4

    Topics: Alopecia; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Drug Eruptions; Female; Head and Neck Neoplasms; Humans; Imiquimod; Lichen Planus; Middle Aged; Scalp; Skin Cream; Skin Neoplasms

2015
Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer.
    Journal of the American Academy of Dermatology, 2011, Volume: 64, Issue:3

    Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Carcinoma, Ductal, Breast; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Imiquimod; Middle Aged; Patched Receptors; Receptors, Cell Surface; Scalp; Skin Neoplasms

2011
Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
    The Journal of dermatological treatment, 2002, Volume: 13, Issue:3

    Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Skin Neoplasms

2002
The use of imiquimod 5% cream for the treatment of basal cell carcinoma as observed in Gorlin's syndrome.
    Clinical and experimental dermatology, 2003, Volume: 28 Suppl 1

    Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms; Treatment Outcome

2003
Topical application of imiquimod for the treatment of high-risk facial basal cell carcinoma in Gorlin syndrome.
    The Journal of dermatological treatment, 2004, Volume: 15, Issue:2

    Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Face; Humans; Imiquimod; Male; Skin Neoplasms; Treatment Outcome

2004
Hundreds of basal cell carcinomas in a Gorlin-Goltz syndrome patient cured with imiquimod 5% cream.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:7

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Humans; Imiquimod; Male; Middle Aged; Ointments; Skin Neoplasms

2006
The use of imiquimod 5% cream for the treatment of superficial basal cell carcinomas in a basal cell nevus syndrome patient.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000, Volume: 26, Issue:6

    Topics: Adjuvants, Immunologic; Aminoquinolines; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Skin Neoplasms

2000